22 August 2016

UK FINANCIAL TIMES: PFIZER TO BUY MEDIVATION (founded 2004) for $14 bn,

MEDIVATION (California) makes XTANDI (enzalutamide) Androgen blocking agent used for metastases from Prostate cancer. Daily dose of 4 x 40mg caps. Ontario govt pays $9962 a month. Pfizer paid 30% premium on Medivation shares.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)